In ORN treatment, PENTO/PENTOCLO achieved complete healing in 54% to 100% of patients, with improved symptoms and reduced need for surgery. The addition of clodronate.

Researchers in France have developed a medical regimen with just pills called PENTOCLO (PENtoxifylline TOcopherol CLOdronate) that cured 76.5% of patients with.

Nevertheless, due to advances in the understanding of ORNJ physiopathology, new treatment alternatives such as the combination of pentoxifylline with tocopherol (PENTO) have emerged. The.

Understanding the Context

Potentiation by Clodronate (PENTOCLO) appears to be effective in ORN of the mandible. The objectives of this study were to evaluate the efficacy and safety of PENTOCLO to treat.

RAPTOR aims to establish the value of the repurposed drug combination Pentoxifylline, Tocopherol & Clodronate (termed PENTOCLO) in treating osteoradionecrosis (ORN) of the mandible. The target.

Retrospective case series and meta-analyses of observational studies suggest that a repurposed triple drug combination pentoxifylline-tocopherol-clodronate (PENTOCLO) may be.

PENTOCLO is a regimen of pentoxifylline, Vitamin E, a bisphosphonate (clodronate) and antimicrobials that has been studied as a treatment modality for patients with ORN of the mandible

Key Insights

Objectives/hypothesis: PENTOCLO treatment, associating pentoxifylline, tocopherol, and clodronate, resolves radiation-induced fibrosis. The main aim of the present study was to prospectively assess.

Results show an improvement in symptom scores, wound healing status, and mean area of exposed bone after an average of 10 months of PENTOCLO therapy. Meaning: This systematic.

A drug combination, PENTOCLO (pentoxifylline, tocopherol, clodronate), purportedly heals most ORN cases with a year-long treatment. While single-arm studies show promise, no randomised controlled.